Lemsip Cough & Cold Capsules with Caffeine
*Company:
Reckitt Benckiser Ireland LimitedStatus:
No Recent UpdateLegal Category:
Supply through general saleActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 04 August 2022
File name
SmPC Lemsip C&C Caps Oct21.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Supply through general sale
Updated on 04 August 2022
File name
PIL Lemsip C&C Caps w Caffeine TR2404752-C- Zippy Oct21 -CRN00CD93.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 01 November 2021
File name
PIL Lemsip C&C Caps w Caffeine Feb21 CRN009859 & CRN008P0X.pdf
Reasons for updating
- New PIL for new product
Updated on 27 October 2021
File name
SmPC Lemsip C&C Caps Feb21.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.6 - Pregnancy and lactation
Legal category:Supply through general sale
Updated on 22 September 2021
File name
SmPC Lemsip C&C Caps Feb21.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.9 - Overdose
Legal category:Supply through general sale
Updated on 12 January 2015
Reasons for updating
- New SPC for new product
Legal category:Supply through general sale
Updated on 12 January 2015
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 6.1 - List of excipients
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
change to section 3 and 6.1
Updated on 10 February 2014
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 6.5 - Added " Not all pack sizes may be marketed"
Section 10 - Updated Date of Revision to December 2013
Section 10 - Updated Date of Revision to December 2013
Updated on 19 October 2012
File name
PIL_14455_783.pdf
Reasons for updating
- New PIL for new product
Updated on 19 October 2012
Reasons for updating
- Change due to user-testing of patient information
Updated on 13 March 2012
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 27 July 2011
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.2 - Posology and method of administration
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 4.2 The following has been deleted "Children 6-12 years: One capsule every 4 hours to a maximum of four doses in any 24 hours"
Not recommended for children under 6 years of age.
The following text has been added; Not recommended for children under 12 years of age.
Section 4.3 the following text has been added ; Contraindictaed in children under 12 years of age
Not recommended for children under 6 years of age.
The following text has been added; Not recommended for children under 12 years of age.
Section 4.3 the following text has been added ; Contraindictaed in children under 12 years of age
Updated on 30 March 2011
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
In section 3, "Lemsip C & C" added to pharmaceutical form
In section 10, Revision of text updated to May 2010
In section 10, Revision of text updated to May 2010
Updated on 30 March 2011
Reasons for updating
- Change to date of revision
- Change to appearance of the medicine
Updated on 19 October 2009
Reasons for updating
- New PIL for new product
Updated on 31 July 2009
Reasons for updating
- New SPC for new product
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
None provided